FAKTOR-ZERTIFIKAT - BOSTON SCIENTIFIC | Real-time Bid/Ask 12:14:13 2024-06-20 pm EDT | ||
| 2.88 EUR / 2.89 EUR | -3.51% |
|
| Current month | -11.01% | ||
| 1 month | -16.01% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-06-20 | 2.9 | -3.01% |
| 24-06-19 | 2.99 | +0.67% |
| 24-06-18 | 2.97 | -1.33% |
| 24-06-17 | 3.01 | +4.51% |
| 24-06-14 | 2.88 | +0.70% |
Delayed Quote Börse Stuttgart
Last update June 20, 2024 at 11:53 am EDT
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK23SX |
| ISIN | DE000JK23SX1 |
| Date issued | 2024-02-23 |
| Strike | 89.03 $ |
| Maturity | Unlimited |
| Parity | 4.14 : 1 |
| Emission price | 10.09 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.2 € |
|---|---|
| Lowest since issue | 2.63 € |
| Spread | 0.01 € |
| Spread % | 0.34% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
76.31
USD
Average target price
82
USD
Spread / Average Target
+7.45%
- Stock Market
- Certificates
- Certificat
